Modulation of Secretion of Interleukin-6 in Brain-Derived Microvascular Endothelial Cells

Publisher Website
Google Scholar
Abstract
Vascular permeability is tightly controlled, in particular in the cerebral microvasculature, thus factors able to modulate permeability are of physiological importance. Interleukin-6 (IL-6) can be released by many cell types including mononuclear phagocytes, fibroblasts and endothelial cells of various origins, and is involved in a variety of cellular responses, including modulation of vascular permeability. IL-6 is synthesized as a precursor propeptide which is proteolytically processed to the active hormone, then degraded, by as yet unknown enzymatic pathways. Unstimulated brain-derived microvessels, primary cells and cell lines, all secreted bioactive IL-6. Cell lines secreted IL-6 exclusively as a 25 kD peptide. In order to understand mechanisms regulating the secretion of IL-6 in cerebral endothelium, levels of IL-6 were measured in cell culture supernatants of brain-derived endothelial cells exposed to dexamethasone, forskolin or dibutyryl cAMP and inhibitors of serine-proteases. In primary cells and in cell lines, dexamethasone and benzamidine (a non-covalent serine-protease inhibitor) significantly and time-dependently decreased, and forskolin, dibutyryl cAMP and 4-(2-aminoethyl)benzene-sulfonyl fluoride (a covalent serine-protease inhibitor) significantly and in a time-dependent fashion increased IL-6 levels in cell culture supernatants. These results demonstrate that IL-6 biological activity is regulated at several steps in cerebral endothelium.